Results 111 to 120 of about 16,265,183 (153)

A narrative literature review on the clinical utility of activated partial thromboplastin time and anti-factor Xa activity assays in cancer patients with anticoagulant therapy. [PDF]

Transl Cancer Res
Li HX, Song LH, Chen YH, Zhao J, Zhang XF.   +4 more
europepmc   +1 more source

Deep learning model for screening causes of activated partial thromboplastin time prolongation using clot waveform analysis at multiple wavelengths. [PDF]

Sci Rep
Matsuda M, Shimomura D, Suzuki T, Tabuchi Y, Kurono H, Nishi K, Arai N, Hoshiyama Y, Kamioka M, Moriyama M, Matsumoto T.   +10 more
europepmc   +1 more source

A Case of Severe Prekallikrein Deficiency Manifesting as Isolated Activated Partial Thromboplastin Time (aPTT) Prolongation. [PDF]

Cureus
Viswanathan D, Sivanandam A, Yeung V.
europepmc   +1 more source

Algorithm-based effective recognition of acquired hemophilia A and other causes of isolated prolonged activated partial thromboplastin time within large blood sample series. [PDF]

Res Pract Thromb Haemost
Turincev P, Gomez F, Coutaz C, Quarroz S, Alberio L, Rufer N.   +5 more
europepmc   +1 more source

Dynamic changes of activated partial thromboplastin time and correlation with mortality in patients with severe fever with thrombocytopenia syndrome: A retrospective cohort study. [PDF]

PLoS Negl Trop Dis
Wang H, Fang S, Wang H, Zheng X.
europepmc   +1 more source

Utility of Activated Partial Thromboplastin Time Screening in Prospective Living Kidney Donors: A Single Center Cohort Study. [PDF]

Kidney Med
Wang LS, Ertmann E, Feldman E, Kossoff M, Lu B, Lin JC, Pishko A, Redfield R, Leonberg-Yoo A, Cuker A.   +9 more
europepmc   +1 more source

A prolonged activated partial thromboplastin time indicates poor short-term prognosis in patients with hepatic encephalopathy: insights from the MIMIC database. [PDF]

Front Med (Lausanne)
Zhan L, Yang Y, Nie B, Kou Y, Du S, Tian Y, Huang Y, Ye R, Huang Z, Luo B, Ge L, Ye S.   +11 more
europepmc   +1 more source

Activated Partial Thromboplastin Time and Anti-IIa Monitoring in Argatroban Anticoagulation in COVID-19 Patients on Venovenous Extracorporeal Membrane Oxygenation. [PDF]

Clin Appl Thromb Hemost
Burša F, Frelich M, Sklienka P, Němcová S, Kučerová Z, Jor O, Romanová T, Kondé A, Janošek J, Sagan J, Máca J.   +10 more
europepmc   +1 more source

A retrospective study of the prevalence of isolated prolongation of activated partial thromboplastin time in the preoperative setting. [PDF]

JA Clin Rep
Watanabe Y, Kato Y, Matsuno T.
europepmc   +1 more source

The evaluation of prothrombin time and activated partial thromboplastin time among diabetic and healthy controls in Africa: systematic review and meta-analysis. [PDF]

Front Med (Lausanne)
Getu F, Alemayehu E, Tesfaye A, Genanew B, Walle M.   +4 more
europepmc   +1 more source